Erik Sulman

31PUBLICATIONS
129CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsGenomics and transcriptomicsCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Sep 29, 2026
Persistent chromatin alterations and gene expression reprogramming follow widespread DNA damage in glioblastoma.

|Mar 19, 2026
NANP targeting radiosensitizes glioblastoma through TNFR1 sialylation-driven mesenchymal shift.

Yingwen Ding, Ze-Yan Zhang, Ravesanker Ezhilarasan

|Aug 08, 2025
Dual Immune Check Point Blockade in MGMT-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial.

Andrew B Lassman, Mei-Yin C Polley, Fabio M Iwamoto

|Jul 16, 2025
Persistent chromatin alterations and gene expression reprogramming follow widespread DNA damage in glioblastoma.

Aram S Modrek, Ken Chandradoss, Catherine Do

|Jul 14, 2025
mtgRNA-db: An annotated database of multi-target CRISPR-Cas9 guide-RNAs in the human genome.

Aram S Modrek, Khoi Huynh, Catherine Do

|Apr 04, 2025
Outcomes of concurrent versus non-concurrent immune checkpoint inhibition with stereotactic radiosurgery for melanoma brain metastases.

Allen Ye Fu, Kenneth Bernstein, Jeff Zhang

Pageof 6

Frequent Collaborators

4 joint publications

Aram S Modrek

4 joint publications

Ze-Yan Zhang

4 joint publications

Aristotelis Tsirigos

3 joint publications

Timothy A Chan